NME7 anticorps (AA 1-150)
Aperçu rapide pour NME7 anticorps (AA 1-150) (ABIN7162044)
Antigène
Voir toutes NME7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-150
-
Réactivité croisée
- Humain, Souris
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human Nucleoside diphosphate kinase 7 protein (1-150AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- NME7 (Nucleoside Diphosphate Kinase (NME7))
-
Autre désignation
- NME7
-
Sujet
-
Background: Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate.
Aliases: MN23H7 antibody, NDK 7 antibody, NDK7_HUMAN antibody, NDP kinase 7 antibody, nm23 H7 antibody, nm23-H7 antibody, NME/NM23 family member 7 antibody, Nme7 antibody, Non metastatic cells 7 protein expressed in (nucleoside diphosphate kinase) antibody, Nucleoside diphosphate kinase 7 antibody
-
UniProt
- Q9Y5B8
Antigène
-